Summary
Clonidine was given orally as monotherapy in increasing daily doses from 3.1 to 25.7 µg/kg to patients with essential hypertension (n=6). When a steady state concentration in plasma was reached at each dose level, the blood pressure (BP) and heart rate were measured during a dosage interval. Effect time — plasma concentration data were submitted to nonlinear regression analysis, which showed that the observed BP effects could be dissociated into depressor and pressor components. A window for the antihypertensive effect was established. At a plasma clonidine concentration of 0.65±0.07 ng/ml 50% of the maximal depressor effect was found, and it was only separated by a factor of 2 from the half maximal pure pressor concentration in plasma. No relationship between the change in heart rate and the plasma clonidine was observed. The findings strengthen the importance of close monitoring of clonidine therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Christensson S, Frisk-Holmberg M, Paalzow L (1979) Steady state plasma concentrations of clonidine and its relation to the effects on blood pressure in normotensive and hypertensive rats. J Pharm Pharmacol 31: 418–419
Dollery LT, Davies DS, Daffran GH, Dargie MB, Dean CR, Phil D, Ried JC, Clare RA, Murray S (1979) Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther 19: 11–17
Edlund PO (1979) Determination of clonidine in human plasma by glass capillary chromatography with electroncapture detection. J Chromatogr 187: 161–169
Frisk-Holmberg M, Edlund PO, Paalzow L (1978) Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients. Br J Clin Pharmacol 6: 227–232
Frisk-Holmberg M (1980) The effectiveness of clonidine as an antihypertensive in a two dose regimen. Acta Med Scand 207: 43–45
Frisk-Holmberg M, Paalzow L, Edlund PO (1981) Clonidine kinetics in man. Evidence for dose dependency and changed pharmacokinetics during chronic therapy. Br J Clin Pharmacol 12: 653–658
Kobinger W (1978) Central α-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81: 40–100
Paalzow L, Edlund PO (1979) Multiple receptor responses: a new concept to describe the relationships between pharmacological effects and pharmacokinetics of drugs. Studies on clonidine in the rat and cat. J Pharmacokinet Biopharm 7: 481–494
Schmitt H (1977) The pharmacology of clonidine and related products in antihypertensive agents. In: Handbuch der experimentellen Pharmakologie. Gross F (ed) Springer, Berlin Heidelberg New York 39: 299–396
Starke K, Docherty JR (1980) Recent developments in α-adrenoceptor research. J Cardiovasc Pharmacol 2: 269–286
Wagner JG (1975) Fundamentals fo clinical pharmacokinetics. Drug Intell Publ (Hamilton, Ill), pp 317–318
Wagner JG (1971) Relationships between drug concentrations and response. J Mond Pharm 14: 279–310
Wallin BG, Frisk-Holmberg M (1981) The antihypertensive effect of clonidine in man. Evidence against a generalized reduction of sympathetic activity. Hypertension 3: 340–346
Wing LMH, Reid JL, Davies DS, Dargie HS, Dollery C (1977) Apparent resistance to the hypotensive effect of clonidine. Br Med J 1: 136–138
Paalzow LK, Edlund PO (1979) Pharmacokinetics of clonidine in the rat and cat. J Pharmacokinet Biopharm 7: 481–494
Author information
Authors and Affiliations
Additional information
SMR Project B81-04-054-14-04
Rights and permissions
About this article
Cite this article
Frisk-Holmberg, M., Paalzow, L. & Wibell, L. Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Eur J Clin Pharmacol 26, 309–313 (1984). https://doi.org/10.1007/BF00548760
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00548760